@inproceedings{inproceedings, title  = {{EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE}},

 url = {{}},

 year = {{2008}},

 month = {{11}},

 author = {{Ducournau P and Latimer N and Sabate E and Walzer S}},

 volume = {{11}},

 journal = {{VALUE HEALTH}},

 issue = {{6}},

 pages = {{A471-A472}},

 note = {{Accessed on 2024/12/22}}}